Results 221 to 230 of about 152,484 (372)

Plant Growth-Promoting Rhizobacteria Colonize Δ⁹-Tetrahydrocannabinolic Acid Drug-Type Cannabis sativa L. Roots and Modulate Cannabinoid Metabolism. [PDF]

Physiol Plant
Tonolo F, Sewalt B, Vrieling K, Choi YH.
europepmc   +1 more source

Advancements in Our Understanding and Management of Cyclic Vomiting Syndrome and Cannabinoid Hyperemesis [PDF]

B U.K. Li, Thangam Venkatesan
openalex   +1 more source

Effect of WIN 55212-2, a Cannabinoid Receptor Agonist, on Aqueous Humor Dynamics in Monkeys [PDF]

, 2003
Fred Y. Chien
openalex   +1 more source

Effects of a Synthetic Cannabinoid on the Reinforcing Efficacy of Ethanol in Rats

, 2021
Ericka M. Bailey
openalex   +2 more sources

Population pharmacokinetic modelling revealed large variability in oromucosal absorption of Δ9‐tetrahydrocannabinol in older patients with poor appetite

British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 504-514, February 2026.
Aim Cannabis‐based medicines are gaining interest and being explored for new therapeutic indications, many of which commonly affect older medical patients. As most previous studies of the population pharmacokinetics of cannabinoids have been performed in healthy adults, this study aimed to investigate the population pharmacokinetics of Δ9 ...
Ida Klitzing Storgaard, Rikke Lundsgaard Nielsen, Morten Baltzer Houlind, Olivia Bornæs, Louise Westberg Strejby Christensen, Aino Leegaard Andersen, Helle Gybel Juul‐Larsen, Lillian Mørch Jørgensen, Torben Breindahl, Baker Nawfal Jawad, Izzet Altintas, Ove Andersen, Trine Meldgaard Lund   +12 more
wiley   +1 more source

Studies of Cannabinoid-Based Products in ClinicalTrials.gov: A Scoping Review. [PDF]

Pharmaceut Med
Haney M, Cooper ZD, VanLaanen H, Hindocha C, Triemstra JL.   +4 more
europepmc   +1 more source

Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA [PDF]

, 2018
Thomas F. Gamage, Charlotte E. Farquhar, Timothy W. Lefever, Julie A. Marusich, Richard C. Kevin, Iain S. McGregor, Jenny L. Wiley, Brian F. Thomas   +7 more
openalex   +1 more source

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

FEBS Letters, 1994
M. Rinaldi-Carmona, F. Barth, M. Héaulme, D. Shire, B. Calandra, Christian Congy, Serge Martinez, J. Maruani, G. Néliat, D. Caput, P. Ferrara, P. Soubrié, J. Breliere, G. Le Fur   +13 more
semanticscholar   +1 more source

Prevalence and reasons for using cannabidiol, delta-8 tetrahydrocannabinol, cannabinol, cannabigerol, and hexahydrocannabinol among US adults. [PDF]

J Cannabis Res
Satybaldiyeva N, Yang KH, Kepner W, Ferran K, Leas EC.   +4 more
europepmc   +1 more source

“Zombie” Outbreak Caused by the Synthetic Cannabinoid AMB‐FUBINACA in New York

New England Journal of Medicine, 2017
A. Adams, S. Banister, Lisandro Irizarry, J. Trecki, M. Schwartz, R. Gerona   +5 more
semanticscholar   +1 more source